Inhibin B: a novel marker of spermatogenesis

被引:63
作者
Pierik, FH
Burdorf, A
de Jong, FH
Weber, RFA
机构
[1] Univ Rotterdam, Ctr Med, Erasmus MC, Dept Publ Hlth, NL-3015 GE Rotterdam, Netherlands
[2] Univ Rotterdam, Ctr Med, Erasmus MC, Dept Androl, Rotterdam, Netherlands
[3] Univ Rotterdam, Ctr Med, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
关键词
anti-Mullerian hormone; inhibin B; male subfertility; puberty; Sertoli cell; testis;
D O I
10.1080/07853890310004084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subfertility affects about 15% of all couples. Assessment of spermatogenesis has a central role in the evaluation of the subfertile couple. Classical markers of spermatogenesis, such as semen analysis, testicular biopsy and endocrine evaluation all have their diagnostic limitations. There is a clear need for accurate additional markers of spermatogenesis. Recently, the serum inhibin B level has emerged as a sensitive endocrine marker of spermatogenesis. This paper summarises the pros and cons of different markers of spermatogenesis, with specific focus on serum inhibin B. The serum inhibin B level has been shown to be associated with classical markers of spermatogenesis, particularly testicular histology, and to be the most accurate endocrine marker of spermatogenesis. A subnormal serum inhibin B level clearly reflects disturbed spermatogenesis. Before puberty, when no spermatogenesis takes place, inhibin B is a marker of testicular integrity. Clinical applications of serum inhibin B in childhood and adulthood are given, and a view on future directions and research is presented. The serum inhibin B level has proven to be valuable in the evaluation of spermatogenesis, and holds a promise for further research.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 59 条
[1]   Serum inhibin B levels reflect sertoli cell function in normal men and men with testicular dysfunction [J].
Anawalt, BD ;
Bebb, RA ;
Matsumoto, AM ;
Groome, NP ;
Illingworth, PJ ;
McNeilly, AS ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3341-3345
[2]   Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone [J].
Anderson, RA ;
Wallace, EM ;
Groome, NP ;
Bellis, AJ ;
Wu, FCW .
HUMAN REPRODUCTION, 1997, 12 (04) :746-751
[3]   Different roles of prepubertal and postpubertal germ cells and sertoli cells in the regulation of serum inhibin B levels [J].
Andersson, AM ;
Müller, J ;
Skakkebæk, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4451-4458
[4]   Longitudinal reproductive hormone profiles in infants:: Peak of inhibin B levels in infant boys exceeds levels in adult men [J].
Andersson, AM ;
Toppari, J ;
Haavisto, AM ;
Petersen, JH ;
Simell, T ;
Simell, O ;
Skakkebæk, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :675-681
[5]   Serum inhibin B levels during male childhood and puberty [J].
Andersson, AM ;
Skakkebæk, NE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 180 (1-2) :103-107
[6]   Permanent effects of neonatal estrogen exposure in rats on reproductive hormone levels, sertoli cell number, and the efficiency of spermatogenesis in adulthood [J].
Atanassova, N ;
McKinnell, C ;
Walker, M ;
Turner, KJ ;
Fisher, JS ;
Morley, M ;
Millar, MR ;
Groome, NP ;
Sharpe, RM .
ENDOCRINOLOGY, 1999, 140 (11) :5364-5373
[7]   Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia [J].
Ballescá, JL ;
Balasch, J ;
Calafell, JM ;
Alvarez, R ;
Fábregues, F ;
de Osaba, MJM ;
Ascaso, C ;
Vanrell, JA .
HUMAN REPRODUCTION, 2000, 15 (08) :1734-1738
[8]   SERUM FSH AND TESTICULAR MORPHOLOGY IN MALE-INFERTILITY [J].
BERGMANN, M ;
BEHRE, HM ;
NIESCHLAG, E .
CLINICAL ENDOCRINOLOGY, 1994, 40 (01) :133-136
[9]   Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia [J].
Brugo-Olmedo, S ;
De Vincentiis, S ;
Calamera, JC ;
Urrutia, F ;
Nodar, F ;
Acosta, AA .
FERTILITY AND STERILITY, 2001, 76 (06) :1124-1129
[10]   Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception [J].
Büchter, D ;
von Eckardstein, S ;
von Eckardstein, A ;
Kamischke, A ;
Simoni, M ;
Behre, HM ;
Nieschlag, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1244-1249